Endorsed by
About
ACORES
The Australian Cardio-Oncology Research & Education Symposium (ACORES) is dedicated to advancing Cardio-Oncology research, clinical practice and collaboration across Australia. We bring clinicians, scientists, and educators together to turn evidence into better care—driving collaboration, innovation, and real improvements in patient outcomes in Australia and beyond.
Join Australia’s premier meeting for clinicians, health practitioners and researchers advancing cancer‑related cardiovascular care.
About the Symposium
Cardio-oncology is a fast-evolving discipline focused on addressing cardiovascular health of cancer therapies. As cancer survival increases globally, the need to manage the cardiovascular effects of treatment is more urgent than ever. The Inaugural ACORES meeting aims to build a multidisciplinary network connecting cardiology, oncology, haematology, radiation oncology, pharmacy, and allied health.
This two-day event will host national and international experts, providing opportunities for collaboration, cutting-edge research presentations, and the development of Australia’s cardio-oncology community.
Join experts across multiple fields, such as Australian-based clinicians and researchers in the field of cardio-oncology, consultant and trainee cardiologists, medical and radiation oncologists, and haematologists, Allied Health Practitioners involved in the care of patients with cancer (nurses, technicians, cancer care coordinators, exercise physiologists, physiotherapists and dieticians) and fundamental, translational and clinical researchers in cardio-oncology and toxicities of anti- cancer therapies
With thanks to the Steering Committee
Dr Daniel Chen, Prof Doan Ngo, Dr Mark Nolan, Dr Satish Ramkumar, Prof Aaron Sverdlov, Dr Sanjeev Kumar, Prof Constantine Tam, Prof Jarad Martin, Dr Phillipa Ell.
Program Themes
Risk Assessment
Baseline cardiovascular risk in cancer patients
Treatment Effects
Drug classes, immunotherapies, vascular toxicities
Specialist Panels
Oncology, haematology, radiation oncology updates
Clinical Trials
Current cardio-oncology research
Indigenous Health
CVD and cancer in Indigenous Australians
Other
Case Discussions, Survivorship & Imaging Advances
Agenda
Survivorship MDT (CT + DC) | Mechanisms, Prevention, and Surveillance of Cardiotoxicity | Beyond Anthracyclines: MDT approach | Other parts of the CO service: Rhythms, Interventions & Technology | Mechanisms, Research & Trials |
|---|---|---|---|---|
Coming of age: long term cancer survivorship and late effects in paediatric, teen, and young adult populations | Cardiac assessment primary prevention in contemporary radiation therapy
Acute, subacute, and late radiation induced cardiotoxicity | Managing cancer treatment and cardiotoxicities in older patients | Digital health/AI in cardio-oncology | Latest trials in cardio-oncology |
Adult cancer survivorship: specialised medicine, or is it just part of good cancer care? | Thrombosis & Haemostasis | New frontiers and dangers in immunotherapy +/- SOCRATES | EP in cancer patients | Emerging cancer therapies – Quo Vadis? - oncologist |
Cardiovascular risk factor management – nurse-led clinics | Cardiovascular risk calculators: Focus on ASCVD? | A cardiologist’s guide to stem cell transplantation/CAR-T/TIL | Interventional Cardiology in cancer patients | Translational Research |
Exercising care in cancer patient: the who, when, and how of exercise in cancer patients | Current State of Play in Cardiac Protection & Imaging Surveillance +/- SUCCOUR-MRI | Prostate cancer and ADT | How to set up a CO service | Cardiotoxicity Models |
Panel Discussion/Case #1 | Panel Discussion/ Case #2 | Panel Discussion/Case #3 | Cases #4 | Round Table Discussion – how to incorporate trials and research into a busy service? |
Speakers
Meet the experts who will be participating in the Symposium
Book your seat
(Tickets are strictly limited, early booking is essential)
